AIMS: To assess health-related quality of life (HRQL) in Spanish outpatients with chronic heart failure (CHF). METHODS: Cross-sectional study carried out in a sample of CHF patients (echocardiography was performed in all of them) followed either in Primary Care (PC) centres or Cardiology outpatient clinics throughout Spain. HRQL was evaluated using the EuroQol 5D (EQ-5D) and Minnesota Living with Heart Failure (MLWHF) Questionnaire. RESULTS: The study subjects were 2161 CHF patients (1412 PC; 749 Cardiology). Patients were older and had more severe disease in PC than in Cardiology settings. Their HRQL scores were likewise worse. After adjusting for clinical variables, the differences in global and physical MLWHF disappeared, but persisted to a smaller degree in EQ-5D and mental MLWHF. HRQL was worse than in a representative sample of the Spanish population and in other chronic conditions such as rheumatoid arthritis or type 2 diabetes, being only comparable to severe chronic obstructive pulmonary disease (COPD). CONCLUSION: All domains of HRQL were significantly impaired in CHF patients. Differences found in HRQL between PC and Cardiology should possibly be attributed to a large extent to the different clinical characteristics of the patients attended. In spite of the differences between EQ-5D and MLWHF, our results suggest that both questionnaires adequately reflect the severity of the disease.
AIMS: To assess health-related quality of life (HRQL) in Spanish outpatients with chronic heart failure (CHF). METHODS: Cross-sectional study carried out in a sample of CHFpatients (echocardiography was performed in all of them) followed either in Primary Care (PC) centres or Cardiology outpatient clinics throughout Spain. HRQL was evaluated using the EuroQol 5D (EQ-5D) and Minnesota Living with Heart Failure (MLWHF) Questionnaire. RESULTS: The study subjects were 2161 CHFpatients (1412 PC; 749 Cardiology). Patients were older and had more severe disease in PC than in Cardiology settings. Their HRQL scores were likewise worse. After adjusting for clinical variables, the differences in global and physical MLWHF disappeared, but persisted to a smaller degree in EQ-5D and mental MLWHF. HRQL was worse than in a representative sample of the Spanish population and in other chronic conditions such as rheumatoid arthritis or type 2 diabetes, being only comparable to severe chronic obstructive pulmonary disease (COPD). CONCLUSION: All domains of HRQL were significantly impaired in CHFpatients. Differences found in HRQL between PC and Cardiology should possibly be attributed to a large extent to the different clinical characteristics of the patients attended. In spite of the differences between EQ-5D and MLWHF, our results suggest that both questionnaires adequately reflect the severity of the disease.
Authors: Giuseppina Majani; Anna Giardini; Cristina Opasich; Robert Glazer; Allen Hester; Gianni Tognoni; Jay N Cohn; Luigi Tavazzi Journal: J Card Fail Date: 2005-05 Impact factor: 5.712
Authors: W J Rogers; D E Johnstone; S Yusuf; D H Weiner; P Gallagher; V A Bittner; S Ahn; E Schron; S A Shumaker; L T Sheffield Journal: J Am Coll Cardiol Date: 1994-02 Impact factor: 24.094
Authors: M Mata Cases; M Roset Gamisans; X Badia Llach; F Antoñanzas Villar; J Ragel Alcázar Journal: Aten Primaria Date: 2003-05-15 Impact factor: 1.137
Authors: A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware Journal: JAMA Date: 1989-08-18 Impact factor: 56.272
Authors: José Antonio Cano Martín; Borja Martínez-Pérez; Isabel de la Torre-Díez; Miguel López-Coronado Journal: J Med Syst Date: 2014-07-04 Impact factor: 4.460
Authors: Daisy J A Janssen; Frits M E Franssen; Emiel F M Wouters; Jos M G A Schols; Martijn A Spruit Journal: Qual Life Res Date: 2011-03-27 Impact factor: 4.147
Authors: Alonso Montiel-Luque; Antonio Jesús Núñez-Montenegro; Esther Martín-Aurioles; Jose Carlos Canca-Sánchez; Maria Carmen Toro-Toro; José Antonio González-Correa Journal: PLoS One Date: 2017-02-06 Impact factor: 3.240
Authors: Francisco S Lozano; José R González-Porras; José R March; José M Lobos; Eduardo Carrasco; Eduardo Ros Journal: Diabetol Metab Syndr Date: 2014-02-17 Impact factor: 3.320